Pneumococcus is rapidly becoming resistant to many antibiotics. This killed, thimerosal-free vaccine is chemically bound to a tiny amount of diphtheria protein to make it more effective than its predecessor, the pneumococcal polysaccharide vaccine. Three initial doses given at least 4 to 8 weeks apart starting at 6 to 8 weeks of age. A booster is given at 12 to 15 months of age. There have been no reports of serious reactions to this vaccine in nearly 40,000 children studied.
Allergic reactions are possible to any biological.
Those who are allergic to latex may experience symptoms because of natural dry rubber in the packaging. Inabiltiy to clot normally may preclude immunization. However, it is far less costly than an office visit and antibiotics for an ear infection, even excluding the cost of x-rays and lab tests for the more serious diseases caused by pneumococcus. We are strongly in favor of administering this vaccine to all children through age 5 and high risk children through 9 years. Let us know of any questions you may have regarding pneumococcal conjugate vaccine.